Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Human Pathology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.HUMPATH.2003.10.025PMID 15116331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathologic Association of Cyclooxygenase 1 and Cyclooxygenase 2 Expression in Gastric Adenocarcinoma

  2001cited by this paper
• Depth of invasion parallels increased cyclooxygenase‐2 levels in patients with gastric carcinoma

  2001cited by this paper
• Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.

  2001cited by this paper
• Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer.

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.

  2000cited by this paper
• Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.

  2000cited by this paper
• Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

  2000cited by this paper
• Localisation of cyclooxygenase 1 and cyclooxygenase 2 inHelicobacter pylori related gastritis and gastric ulcer tissues in humans

  2000cited by this paper
• Overexpression of cyclooxygenase‐2 protein is less frequent in gastric cancers with microsatellite instability

  1999cited by this paper
• Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma

  1999cited by this paper
• Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.

  1999cited by this paper
• Extended lymph-node dissection for gastric cancer.

  1999cited by this paper
• Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer

  1999cited by this paper
• Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice.

  1998cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  1998cited by this paper
• Expression of cyclooxygenase‐2 protein in gastric adenocarcinoma

  1998cited by this paper
• Prognostic value of bcl-2 expression in gastric cancer.

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

  1996cited by this paper
• Expression of Thymidine Phosphorylase in Human Gastric Carcinoma

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Aspirin use and risk of fatal cancer.

  1993cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

  1988cited by this paper
• Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

  1988cited by this paper
• Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.

  1987cited by this paper
• TNM Classification of Malignant Tumours

  1987cited by this paper
• Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors.

  1980cited by this paper

• Association between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study.

  2022cites this paper
• Immunotherapy in endometrial cancer: rationale, practice and perspectives

  2021cites this paper
• Gastric carcinogenesis: a comprehensive review of the angiogenic pathways

  2020cites this paper
• Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.

  2019cites this paper
• Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice

  2019cites this paper
• The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.

  2018cites this paper
• Relationship between expression of cyclooxygenase 2 and neovascularization in human pterygia

  2017cites this paper
• Cyclooxygenase-2 and Vascular Endothelial Growth Factor Expression and Their Correlation with Angiogenesis in Gastric Carcinomas

  2016cites this paper
• JMJD2B is required for Helicobacter pylori-induced gastric carcinogenesis via regulating COX-2 expression

  2016cites this paper
• Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?

  2015cites this paper
• Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma.

  2015cites this paper
• Cyclooxygenase-2 Expression Is Associated with Poor Overall Survival of Patients with Gastric Cancer: A Meta-Analysis

  2014cites this paper
• Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility study.

  2014cites this paper
• Expression of Cox 2 in Gastric Mucosa of Patients with Gastric Carcinoma and Its Correlation with the Disease Progression

  2014cites this paper
• Cyclooxygenase-2 inhibition as a strategy for treating gastric adenocarcinoma.

  2014cites this paper
• The 765G>C polymorphism in the cyclooxygenase-2 gene and gastric cancer risk: an update by meta-analysis.

  2014cites this paper
• Mesenchymal Stromal Cell Dependent Regression of Pulmonary Metastasis from Ewing’s

  2014cites this paper
• The -765G>C polymorphism in the cyclooxygenase-2 gene and digestive system cancer: a meta-analysis.

  2014cites this paper
• Expression of Cyclooxygenase-2 (COX-2) in Helicobacter Pylori Premalignant and Malignant Gastric Lesion, the Association with Tumor Angiogenesis.

  2013cites this paper
• Helicobacter pylori γ-glutamyl transpeptidase: a formidable virulence factor.

  2013cites this paper
• Prognostic Significance of COX-2 Expression and Correlation With Bcl-2 and VEGF Expression, Microvessel Density, and Clinical Variables in Classical Hodgkin Lymphoma

  2013cites this paper
• Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor

  2013cites this paper
• Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls

  2013cites this paper
• Chapter The Role of Cyclooxygenases and Lipoxygenases in the Regulation of Tumor Angiogenesis

  2013cites this paper
• Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial

  2013cites this paper
• The Effect of Helicobacter pylori on Epidermal Growth Factor Receptor-Induced Signal Transduction and the Preventive Effect of Celecoxib in Gastric Cancer Cells

  2013cites this paper
• Streptococcus infantarius and carcinogenesis: a new chapter in colorectal pathology

  2013cites this paper
• Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases.

  2012cites this paper
• The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea

  2012cites this paper
• Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression.

  2011cites this paper
• Involvement of Nuclear Factor κB (NF-κB) in the Downregulation of Cyclo-Oxygenase-2 (COX-2) by Genistein in Gastric Cancer Cells

  2011cites this paper
• Cyclooxygenase-2 Is an Independent Predictor of Poor Prognosis in Uterine Leiomyosarcomas

  2011cites this paper
• MODELING OF COX-2 INHIBOTORY ACTIVITY OF FLAVONOIDS Research Article

  2011cites this paper
• Cyclooxygenase-2 and Gastric Cancer

  2011cites this paper
• Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy

  2011cites this paper
• Prognostic significance of cyclooxygenase-2 and associated molecules in gastric cancer

  2011cites this paper
• Cyclooxygenase-2 and Survivin in Superficial Urothelial Carcinoma of the Bladder and Correlation with Intratumoural Microvessel Density

  2010cites this paper
• Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer

  2010influential citation
• Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision- Like Protein HuR in Gallbladder Carcinoma

  2010cites this paper
• Peroxisome proliferator-activated receptor delta and gastric cancer (Review).

  2009cites this paper
• Inflammation and cancer: how friendly is the relationship for cancer patients?

  2009cites this paper
• Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Carcinoma Patients Receiving Adjuvant Chemotherapy and Is Not Associated with EBV Infection

  2009cites this paper
• Cytoplasmic expression of HuR is related to cyclooxygenase-2 expression in colon cancer.

  2009cites this paper
• Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.

  2009cites this paper
• Cancer-Stromal Cell Interaction and Tumor Angiogenesis in Gastric Cancer

  2009cites this paper
• Prostaglandin and Transforming Growth Factor β Signaling in Gastric Cancer

  2009cites this paper
• Microsomal prostaglandin E synthase protein levels correlate with prognosis in colorectal cancer patients

  2009cites this paper
• Inhibiting platelet-derived growth factor beta reduces Ewing's sarcoma growth and metastasis in a novel orthotopic human xenograft model.

  2009cites this paper
• Peroxisome proliferator-activated receptor δ and gastric cancer (Review)

  2009cites this paper
• The pro-apoptotic action of stilbene-induced COX-2 in cancer cells: Convergence with the anti-apoptotic effect of thyroid hormone

  2009cites this paper
• Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells.

  2009cites this paper
• Recent advances and developments in treatment strategies against pancreatic cancer.

  2009cites this paper
• Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.

  2008cites this paper
• In vivo microvascular response of murine cutaneous muscle to ibuprofen‐releasing polyurethane foam

  2008cites this paper
• COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells.

  2008cites this paper
• Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer

  2008cites this paper
• Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.

  2008cites this paper
• The Effect of H. pylori on the EGFR-induced Signal Transduction and Preventive Effect of Celecoxib in the Gastric Cancer Cells

  2008cites this paper
• Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma.

  2008cites this paper
• Celecoxib Inhibits Apurinic/Apyrimidinic Endonuclease-1 Expression and Prevents Gastric Cancer in Helicobacter pylori-Infected Mongolian Gerbils

  2008cites this paper
• Correlation Between Cyclooxygenase-2 Expression and HuR Cytoplasmic Translocation of Breast Cancer

  2008cites this paper
• Positive VEGF Immunostaining Independently Predicts Poor Prognosis in Curatively Resected Gastric Cancer Patients: Results of a Study Assessing a Panel of Angiogenic Markers

  2008cites this paper
• Expressão dos genes COX-2 e HER-3 em câncer de pulmão por PCR em tempo real

  2008cites this paper
• Expression of Embryonic Lethal Abnormal Vision (ELAV)-Like Protein HuR and Cyclooxygenase-2 (COX-2) in Ewing Sarcoma

  2008cites this paper
• Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.

  2007cites this paper
• Correlations between Expression of Tumor-Related Proteins and COX-2 in Gastric Cancer

  2007cites this paper
• Celecoxib Inhibits Cdx2 Expression and Prevents Gastric Cancer in Helicobacter pylori-Infected Mongolian Gerbils

  2007cites this paper
• Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival

  2007cites this paper
• Effect of celecoxib on E-cadherin, VEGF, microvessel density and apoptosis in gastric cancer

  2007cites this paper
• The distinct role of cyclooxygenase-2 in prostate and bladder carcinogenesis

  2007cites this paper
• Clinical significance of prostaglandin E synthase expression in gastric cancer tissue.

  2007cites this paper
• Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China.

  2006cites this paper
• Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas.

  2006cites this paper
• A Multiplex Tissue Immunoblotting Assay for Proteomic Profiling: A Pilot Study of the Normal to Tumor Transition of Esophageal Squamous Cell Carcinoma

  2006cites this paper
• Expression of cyclo‐oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor β1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine

  2006cites this paper
• Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables

  2006cites this paper
• Increasing cyclooxygenase‐2 (cox‐2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl‐2

  2006cites this paper
• Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.

  2006cites this paper
• Cyclooxygenase-2 Expression Correlates With Membrane-Type-1 Matrix Metalloproteinase Expression in Colorectal Cancer Tissue

  2006cites this paper
• Cyclooxygenase-2 expression in chronic gastritis and gastric carcinoma, correlation with prognostic parameters.

  2006cites this paper
• Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma

  2005cites this paper
• VEGF as a Target of Therapy in Gastrointestinal Oncology

  2005cites this paper
• Levamisole Inhibits Angiogenesis in vitro and Tumor Growth in vivo

  2005cites this paper
• Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma

  2005cites this paper
• Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-κB/Cyclooxygenase-2 Signaling Pathway

  2005cites this paper
• Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Cancer and Its Expression Is Regulated by the Messenger RNA Stability Factor HuR

  2005cites this paper
• Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications

  2005cites this paper
• Cyclooxygenase-2 Overexpression Is Associated with a Poor Outcome in Resected Ampullary Cancer Patients

  2005cites this paper
• New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy.

  2005cites this paper
• Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts.

  2004cites this paper